FF 
Principal Investigator/Program Director (Last, first, middle): 
Haubrich, Richard H. 
BIOGRAPHICAL SKETCH 
Give the following information for the key personnel and consultants and collaborators. Begin with the principal 
investigator/program director. Photocopy this page for each person. 
NAME 
POSITION TITLE 
Richard H. Haubrich, M.D. 
Co-Investigator 
EDUCTION (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.) 
INSTITUTION AND LOCATION 
DEGREE 
YEAR 
CONFERRED 
FIELD OF STUDY 
Occidental College, Los Angeles, CA 
B.A 
1979 
Chemistry 
USC School of Medicine, Los Angeles, CA 
M.D. 
1983 
Medicine 
’ RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present position, list, in chronological order, previous employment, experience and 
| honors. Key personnel include the principal investigator and any other individuals who participate in the scientific development or execution of the project. 
Key personnel typically will include all individuals with doctoral or other professional degrees, but in some projects will include individuals at the masters or 
; baccalaureate level provided they contribute in a substantive way to the scientific development or execution of the project. Include present membership on 
any Federal Government public advisory committee. List, in chronological order, the titles, all authors, and complete references to all publications during the 
| past three years and to representative earlier publications pertinent to this application. DO NOT EXCEED TWO PAGES. 
RESEARCH AND PROFESSIONAL EXPERIENCE 
1987 - 1990 Fellow, University of Massachusetts Medical Center, Worcester, MA 
1990 - 1991 Assistant Professor of Medicine, Department of Medicine, University of Massachusetts 
Medical Center, Worchester, MA 
1991 - Pres. Assistant Clinical Professor of Medicine, Department of Medicine, UCSD, San Diego, CA 
HONORS 
1990 
Maxwell Finland Young Investigators Award 
PUBLICATIONS 
1 . SwendlQw, N., and Haubrich, R. (1 987). "Aggressive treatment of a patient with the acquired immune 
deficiency syndrome." (letter) Annals of Internal Medicine. 1 07:597. 
2. Haubrich, R.H., Tukeda, A., Kofff, W ., Smith, C., and Ennis, F.A. "Lack of FCR mediated enhancement in 
sera from recipients of RGP160 experimental HIV vaccine." VII Int'l. Confr. AIDS. Abstract MA 1327. 
PUS 398 (Rev. 9/91) 
Number pages consecutively a 
(Form Page 6) Page 
throughout th^^ ^ljip^t ipn^go nof use suffixes such as 3a, 3b. 
[715] 
